1. Home
  2. SNDX vs NOMD Comparison

SNDX vs NOMD Comparison

Compare SNDX & NOMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Syndax Pharmaceuticals Inc.

SNDX

Syndax Pharmaceuticals Inc.

HOLD

Current Price

$22.19

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo Nomad Foods Limited

NOMD

Nomad Foods Limited

HOLD

Current Price

$10.78

Market Cap

1.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNDX
NOMD
Founded
2005
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.8B
IPO Year
2014
2015

Fundamental Metrics

Financial Performance
Metric
SNDX
NOMD
Price
$22.19
$10.78
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
5
Target Price
$80.23
$17.40
AVG Volume (30 Days)
1.1M
1.5M
Earning Date
05-25-2026
01-01-0001
Dividend Yield
N/A
6.20%
EPS Growth
11.56
N/A
EPS
N/A
N/A
Revenue
$172,352,000.00
N/A
Revenue This Year
$619.64
$3.48
Revenue Next Year
$115.96
$1.18
P/E Ratio
N/A
$8.38
Revenue Growth
627.84
N/A
52 Week Low
$8.59
$10.67
52 Week High
$22.73
$20.81

Technical Indicators

Market Signals
Indicator
SNDX
NOMD
Relative Strength Index (RSI) 61.76 25.04
Support Level $19.59 N/A
Resistance Level $22.33 $12.36
Average True Range (ATR) 1.02 0.32
MACD 0.13 -0.26
Stochastic Oscillator 87.03 2.28

Price Performance

Historical Comparison
SNDX
NOMD

About SNDX Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Its product candidates include revumenib and axatilimab. It is developing revumenib, a selective menin-MLL inhibitor for KMT2A-rearranged (MLL-r) and NPM1-mutant acute leukemias, including ALL and AML. It is also developing axatilimab, a CSF-1R-blocking antibody for cGVHD and idiopathic pulmonary fibrosis. Entinostat is its oral, small molecule product candidate that has direct effects on both cancer cells and immune regulatory cells. The business activity of the group is functioned through the region of the United States.

About NOMD Nomad Foods Limited

Nomad Foods Ltd is a packaged foods company that is involved in the business of manufacturing and distribution of branded frozen foods in Western Europe. The company manufactures and markets frozen food products such as fish, vegetables, poultry, Ice Cream and ready meals like pizza. It sells its products through large grocery retailers under the brand Birds Eye in the United Kingdom and Ireland, Findus in Italy, France, Spain, and Scandinavia, and Iglo in Germany and other continental markets. The company operates through a single segment being Frozen. The majority of the revenue is generated from the United Kingdom.

Share on Social Networks: